Company profile for Isifer

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Isifer, founded in 2001, is a privately held company focused on innovative solutions in women?s health. Spun out of research at the Karolinska Institute in Sweden, Isifer has developed two breakthrough therapies based on the well-established drug Lidocaine: Endole? for endometriosis and Isifera? for infertility. Both products are administered via Fallopian tube flushing (perturbation). Clinical phase studies have confirmed pro...
Isifer, founded in 2001, is a privately held company focused on innovative solutions in women?s health. Spun out of research at the Karolinska Institute in Sweden, Isifer has developed two breakthrough therapies based on the well-established drug Lidocaine: Endole? for endometriosis and Isifera? for infertility. Both products are administered via Fallopian tube flushing (perturbation). Clinical phase studies have confirmed proof of concept, along with favorable safety and tolerability, with no observed side effects. These therapies offer novel, non-invasive treatment options for underserved conditions.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Sweden
Address
Address
Sv
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

AMWC Asia-TDAC

AMWC Asia-TDAC

Not Confirmed

envelop Contact Supplier

AMWC Asia-TDAC

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty